Hongli Group Inc. Entered into Strategic Non-Binding MOU with Sidus Energy Storage, Inc. to Explore Potential Advanced Battery Manufacturing Collaboration

Parabilis reported a 72% response rate for its drug, comparing it to published data of 41% for nirogacestat and 55.7% for varegacestat. The company plans a Phase III trial for 2027, with a regimen of 450 mg weekly followed by 300 mg every two weeks. Parabilis has aligned with the FDA on the trial design, aiming for a broad patient population and progression-free survival as the primary endpoint.

Intel will manufacture a chip for Tesla using its 14A process, though the specific chip remains undisclosed. Intel aims to prove its foundry capabilities against competitors like TSMC and Samsung. Tesla may use the chip for AI or infotainment systems, with production potentially starting around 2028. Intel also announced a $20 billion equity raise for factory expansion.

Amgen announced that adding IMDELLTRA to IMFINZI reduced the hazard of death by 58% in a Phase 3 lung-cancer trial. The company's stock closed at $439.26 on Friday, trading at 19.2 times its adjusted earnings midpoint of $22.90. A 10% share-price gain would require roughly $1.25 billion more in annual adjusted net income, according to TECHi's calculations.

Vertex Pharmaceuticals (VRTX) generated $3.33B in Q2 revenue, with 96% from cystic fibrosis (CF) therapies. The company expects $500M+ in 2026 sales from non-CF treatments, including Journavx and Casgevy. Positive trial data for inaxaplin, a potential $1B+ therapy, and acquisitions like Crinetics support diversification. Vertex raised its full-year revenue guidance to $13.1B-$13.2B.

Tesla (TSLA) and Nvidia (NVDA) plan to invest $2.8 billion in Samsung Electro-Mechanics to expand production of advanced substrates for AI processors. Nvidia will contribute $2.0 billion, while Tesla will invest $829.9 million for a five-year supply of substrates. Samsung expects Nvidia to become a major customer by 2028, with both companies aiming to secure supply chains for AI and autonomous-driving technologies.

Five major Bitcoin miners (IREN, Core Scientific, Bitfarms, TeraWulf, Cipher) cut production by 47% YoY, redirecting resources to AI. Total BTC output fell from 13,263 to 7,075. They secured $50B in AI contracts. Bitcoin's hash rate rebounded 11.7% since August, with new miners offsetting losses. Higher BTC prices improved mining economics, reducing selling pressure.